NCT04908475 · Interventional trial
Study of Subcutaneous Risankizumab Injection Compared to Oral Apremilast Tablets to Assess Change in Disease Activity And Adverse Events in Adult Participants With Moderate Plaque Psoriasis Who Are Candidates for Systemic Therapy
Overall registry status Completed
Phase 4
Conditions Psoriasis
Delaware Valley sites
- Psoriasis Treatment Center of Central New Jersey /ID# 228943 · East Windsor, NJ · Mercer County
First posted
Registry updated
Added to the directory